These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25230674)
1. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites. Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW Org Biomol Chem; 2014 Nov; 12(41):8132-7. PubMed ID: 25230674 [TBL] [Abstract][Full Text] [Related]
2. Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors. Hutton JA; Goncalves V; Brannigan JA; Paape D; Wright MH; Waugh TM; Roberts SM; Bell AS; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW J Med Chem; 2014 Oct; 57(20):8664-70. PubMed ID: 25238611 [TBL] [Abstract][Full Text] [Related]
3. Identification of Selective Inhibitors of Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752 [TBL] [Abstract][Full Text] [Related]
4. Novel Thienopyrimidine Inhibitors of Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors. Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585 [TBL] [Abstract][Full Text] [Related]
7. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design. Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368 [TBL] [Abstract][Full Text] [Related]
9. Designing Ligands for Leishmania, Plasmodium, and Aspergillus N-Myristoyl Transferase with Specificity and Anti-Target-Safe Virtual Libraries. Garcia-Sosa AT Curr Comput Aided Drug Des; 2018; 14(2):131-141. PubMed ID: 29521245 [TBL] [Abstract][Full Text] [Related]
10. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode. Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the discovery of N-myristoyltransferase inhibitors. Zhao C; Ma S ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080 [TBL] [Abstract][Full Text] [Related]
12. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major. Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives. Zhong Y; Han X; Li S; Qi H; Song Y; Qiao X Chem Pharm Bull (Tokyo); 2017; 65(10):904-910. PubMed ID: 28966274 [TBL] [Abstract][Full Text] [Related]
15. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy. Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure. Yamazaki K; Kaneko Y; Suwa K; Ebara S; Nakazawa K; Yasuno K Bioorg Med Chem; 2005 Apr; 13(7):2509-22. PubMed ID: 15755653 [TBL] [Abstract][Full Text] [Related]